Towards Healthcare

SEARCH RESULT FOR

CRISPR

February 19, 2026

CRISPR Market Size and Analysis (2026-2035)

  • Status : Published
  • No. of Pages: 150+
  • Category : Biotechnology

According to market projections, the CRISPR sector is expected to grow from USD 3.27 billion in 2025 to USD 9.49 billion by 2035, reflecting a CAGR of 11.24%. The market is growing due to rising demand for gene-editing therapies in genetic disorders ...

November 01, 2025

CRISPR Technology Market Size, Genetic and Targeted Therapies

  • Status : Published
  • No. of Pages: 150+
  • Category : Biotechnology

According to market projections, the CRISPR technology sector is expected to grow from USD 5.72 billion in 2024 to USD 26.22 billion by 2034, reflecting a CAGR of 16.54%. In 2024, North America led the global CRISPR technology market, while Asia-Paci...

January 05, 2026

CRISPR Gene Editing Market Evolves with Expansion of CRO Services

  • Status : Published
  • No. of Pages: 150+
  • Category : Healthcare Services

According to market projections, the CRISPR gene editing sector is expected to grow from USD 4.76 billion in 2025 to USD 18.89 billion by 2035, reflecting a CAGR of 14.77%. In 2024, North America led the CRISPR gene editing market, while Asia-Pacific...

November 01, 2025

Nonspecific Endonuclease Market Growth Driven by Clinical Trials and CRISPR-Cas9 Innovations in 2025

  • Status : Published
  • No. of Pages:
  • Category : Biotechnology

According to market projections, the nonspecific endonuclease market size to capture US$ 424.58 mn in 2025 and is to soar US$ 641.37 mn by 2030. The nonspecific endonuclease market is growing, driven by demand in gene therapy and genetic engineering,...

October 08, 2025

Pneumonia Testing Market Insights 2025: Tulane’s CRISPR Breakthrough and Lunit AI Imaging Drive Diagnostic Innovation

  • Status : Published
  • No. of Pages: 150+
  • Category : Diagnostics

Market insights predict, the pneumonia testing industry is expected to grow from USD 1.97 billion in 2024 to USD 3.85 billion by 2034, driven by a CAGR of 6.97%. The rising prevalence of pneumonia and the growing demand for early diagnosis drive the ...